Saint Joseph's Translational Research Institute
The Center for Translational Research
Home Contact Us Calendar St Josephs Hospital
Search GO
About Us
Preclinical Research
Clinical Research
Education
News
Clinical Trials

Saint Joseph's Translational Research Institute

Home > Saint Joseph's Translational Research Institute > In The News

Journal Club

 

Saint Joseph’s Translational Research Institute is pleased to announce the addition of the SJTRI Journal Club to the SJHA campus. Our move of the journal club seminar venue over to the hospital represents an important bridge we are building form SJTRI Preclinical to SJTRI Clinical, Saint Joseph’s Hospital of Atlanta, and the Saint Joseph's Heart and Vascular Institute.

We encourage anyone who is interested in attending the seminars at the hospital to join us and discover how the biomedical scientific backgrounds of our research endeavors translate from the bench to the patient bedside. Additionally, assisting in translating how your day-to-day activities can help move medical science forward; we encourage attendees to approach any of the scientific staff with questions for discussion.

If you are interested in attending, please contact one of our schedulers to reserve a time at (678) 843-6501

   
Past Journal Clubs
April 2008 May
2008
June
2008
July
2008
         
   
08/13/08

Therapeutic Benefit of IL-10 in Myocardial Infarction: Inhibition of T-cell Mediated Inflammation

  Presenter: Dr. Traci Goodchild, PhD
 

Bone marrow-derived progenitor cells have been used clinically to improve left ventricular function in patients after myocardial infarction however the mechanisms for this improvement have not been clearly defined.

Progenitor cell production of IL-10 may act to reduce T-cell infiltration in the infarcted myocardium and as a consequence, reducing inflammation while preserving contractile function in existing myocytes and maintaining blood flow in vessels.

Associated Documents

   
08/27/08

Endothelial Cell Recovery Between Comparator Polymer-Based Drug-Eluting Stents

  Presenter: Dr. Dong Ming Hou, MD, PhD
 

Although the underlying mechanisms of LST are poorly understood, endothelial re-growth is an essential to provide critical structural and antithrombotic functions". Dr. Virmani’s team investigated stent coverage by endothelium post implanting either BMS, or DES eluting sirolimus, paclitaxel, zotarolimus, or everolimus in an endothelial denuded rabbits iliac.

At 14 days, the best result was seen only for everolimus-eluting stent and BMS. At 28 days, there was no difference between all stent types. "This finding may be of clinical importance because dysfunctional endothelium combined with a lack of endothelial coverage MAY play a role in late stent thrombosis

Associated Documents

   
   
   
   
   
   
   
   

 

Related Topics
 
Physician News
 
Press Release
 
Journal Club
 
 
Media Room | Mission | Privacy Policy | Disclaimer | Site Map

Saint Joseph's Translational Research Institute
5673 Peachtree Dunwoody Road, N.E. • Suite 675 • Atlanta, Georgia 30342